A1C Goals for a 75-Year-Old Woman
For a 75-year-old woman with diabetes, target an HbA1c of 7.5-8.0% in most cases, with the specific goal determined by her overall health status, comorbidities, functional status, and hypoglycemia risk. 1, 2
Health Status-Based Approach
The 2019 Endocrine Society guideline provides the most comprehensive framework for older adults, categorizing patients into three groups 1:
Healthy Older Adults (Few comorbidities, intact cognition/function)
- Target: 7.0-7.5% 2
- These patients can manage complex medication regimens
- They have sufficient life expectancy to benefit from microvascular complication prevention
- Lower targets are appropriate if achievable without hypoglycemia
Complex/Intermediate Health (Multiple chronic conditions OR 2+ instrumental ADL impairments OR mild-moderate cognitive impairment)
- Target: <8.0% 2, 3
- This represents the majority of 75-year-old patients
- Comorbidities affect self-management abilities and increase hypoglycemia risk
- The framework prioritizes glucose ranges over HbA1c: fasting 100-150 mg/dL, bedtime 150-180 mg/dL 1
Very Complex/Poor Health (Nursing home residents OR end-stage chronic illness OR moderate-severe cognitive impairment OR 2+ ADL dependencies)
- Target: Avoid reliance on HbA1c; focus on glucose 100-200 mg/dL 3
- Avoid symptomatic hyperglycemia and any hypoglycemia
- No benefit from tight control in this population
- Goals should minimize treatment burden
Critical Safety Considerations
Never target HbA1c <6.5% in older adults - this is associated with increased mortality and hypoglycemia without additional benefit 2, 4. The ACCORD trial demonstrated 20% higher mortality with intensive targets <6.5% in older adults with multiple comorbidities 1.
Red Flags Requiring Higher Targets (8-9%):
- History of severe hypoglycemia or hypoglycemia unawareness 1, 2
- Taking insulin or sulfonylureas 5, 4
- Advanced kidney disease (CKD stage 4-5) - insulin clearance is impaired 5
- Limited life expectancy (<10 years) 4
- High fall risk 3
- Living alone without caregiver support 3
Practical Implementation
Prioritize glucose monitoring over HbA1c alone 1. HbA1c fails to identify hypoglycemia risk and has accuracy concerns in older adults. Consider continuous glucose monitoring to assess glucose patterns and time-in-range, particularly if hypoglycemia is suspected.
Deintensify therapy if 3:
- HbA1c <6.5% on any glucose-lowering medication
- Severe or recurrent hypoglycemia occurs
- Functional or cognitive decline develops
- Social circumstances change (loss of caregiver, financial difficulties)
Evidence Strength
The American Geriatrics Society guideline 2 provides Level 1A evidence for HbA1c targets of 7-8% in older adults, with Level IIA evidence supporting 8-9% targets in those with multiple comorbidities. Recent observational data from 1,841 older adults showed that those with very complex/poor health and HbA1c ≥8% had 76% higher mortality risk compared to <7%, but importantly, those with HbA1c <7% were not at elevated risk regardless of health status 6.
The key clinical decision point: Assess whether your 75-year-old patient is functionally independent with few comorbidities (target 7.0-7.5%) versus having multiple conditions or functional limitations (target <8.0%). If she has advanced frailty, nursing home residence, or limited life expectancy, abandon HbA1c targets entirely and focus on avoiding symptomatic glucose extremes.